Trademark: 90836060
Word
EVAMPLIX (BALSTILIMAB)
Status Date
Monday, May 1, 2023
Filing Date
Monday, July 19, 2021
Published for Opposition
Tuesday, August 2, 2022
Abandoned Date
Monday, May 1, 2023
5 pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
The mark consists of a two dimensional representation of three interconnected cubes, with a single cube resting on top of two cubes to the right of the term "EVAMPLIX," which is above the term "(BALSTILIMAB)".
"BALSTILIMAB"
May 1, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 1, 2023
Abandonment - No Use Statement Filed
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 30, 2022
Approved For Pub - Principal Register
Jun 29, 2022
Teas/Email Correspondence Entered
Jun 29, 2022
Correspondence Received In Law Office
Jun 29, 2022
Teas Response To Office Action Received
Dec 30, 2021
Notification Of Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action Written
Dec 30, 2021
Previous Allowance Count Withdrawn
Nov 23, 2021
Withdrawn From Pub - Og Review Query
Nov 9, 2021
Approved For Pub - Principal Register
Nov 9, 2021
Examiner's Amendment Entered
Nov 9, 2021
Notification Of Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment -Written
Nov 8, 2021
Assigned To Examiner
Sep 22, 2021
Notice Of Design Search Code E-Mailed
Sep 21, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24